Filing Details

Accession Number:
0001209191-23-031512
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-22 17:03:17
Reporting Period:
2022-07-01
Accepted Time:
2023-05-22 17:03:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818331 Genedx Holdings Corp. WGS Services-Health Services (8000) 851966622
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1873901 Anthony Prentice C/O Genedx Holdings Corp.
333 Ludlow St, North Tower, 6Th Fl.
Stamford CT 06902
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2022-07-01 4,576 $0.00 14,436 No 4 M Direct
Class A Common Stock Disposition 2022-07-05 1,828 $1.32 12,608 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Restricted Stock Unit Disposition 2022-07-01 4,576 $0.00 4,576 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
68,642 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
  2. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.215 to $1.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. 6.25% of the total shares underlying the restricted stock units vest in quarterly installments beginning on July 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.